Registration
MCDERMOTT WILL & SCHULTE LLP for SANOFI-AVENTIS U.S. INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA approval of follow on biologics, including S. 1679
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL WILLIAM RADENSKY New | — |
| SHEILA D WALCOFF New | (Immediate Office of the Secretary), U.S.Department of ; ; Health/Human Services; 2004-06: Assoc Commissioner for ; ; External Affairs, U.S. FDA; 1998-99: Majority Counsel, ; ; Armed Services Committee, U.S. House of Representatives |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI-AVENTIS | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.